NEW YORK (GenomeWeb News) – DCN Diagnostics today announced a deal with Asahi Kasei Fibers for the distribution of Asahi's cellulose nanobead product in North America.

Additionally, DCN, formerly called Diagnostic Consulting Network, will be the preferred provider of original equipment manufacturing services to users of Asahi's product, called NanoAct, worldwide, except in Japan, where Asahi is based.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.